We believe Africa
will revolutionize the
global genomics market"

About Us

54gene was founded in 2019 by Dr. Abasi Ene-Obong to address the significant gap in the global genomics market: Nearly 90% of genetic material used in pharmaceutical research is caucasian. Only 2% is African, despite the fact that Africans and people of African ancestry are more genetically diverse than all other world populations combined.

As a result, pharmaceutical research and development is lacking the diverse data that may hold the key to medical discoveries and new healthcare solutions.

54gene aims to unlock the African genome by building the world’s first and largest pan-African biobank. Together with other pharmaceutical and biotech partners, we will study this dataset to identify diagnostic and therapeutic targets that benefit people all over the world.

Our Investors

Meet Our Team

Abasi Ene-Obong PhD

Chief Executive Officer

Delali Attipoe

Chief Operations Officer

Jessica Rich

Chief Commercial Officer

Francis Osifo

VP of Engineering & Head of Technology, Africa

Estelle Dogbo

VP of Diagnostics & Country Head, Nigeria

Dr. Jumi Popoola

Director of Scientific Services, Africa

Dr. Zara Modibbo

VP Laboratory OperationsHead of Clinical Laboratory Services, Africa

Dr. Nabila Ado Wanka

Head of Histopathology

Yemisi Osakwe

Director of Provider Engagement

Ijeoma Onuoha

Senior Manager, Ecosystem Partnerships, Africa

Abi Galadima

Chief of Staff

Excited about building
Africa’s fastest growing
genomics company?
Join us.

View open positions

Join Us On Our Journey